ArticleScience progress
Intelligent prediagnosis for nontraumatic acute abdomen with surface-level information using machine learning.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An explainable predictive machine learning model of oxaliplatin induced peripheral neuropathy based on clinical data: a retrospective single center.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectivePrediagnosis of diseases plays a pivotal role in medical triage. However, only surface-level information is available in this medical service. To achieve the prediagnosis challenge for nontraumatic acute abdomen (NTAA) with limited information, an intelligent framework was proposed.MethodsThis research was conducted using retrospective patients with NTAA data from the Affiliated Hospital of Zunyi Medical University. A machine learning framework, which encompassed a series of combined binary classifiers tailored to various NTAA conditions was developed. Within this framework, disease information was recursively inferred across three tiers: primary categories (I-level), disease subtypes (II-level), and specific diseases (III-level). In model training, the REFCV (Recursive Feature Elimination with Cross-Validation) approach was employed for feature refinement, and five algorithms-Logistic Regression, Deep Neural Networks, Support Vector Machine, Random Forest, and eXtreme Gradient Boosting-were assessed. The data was split into training and testing datasets, with five-fold cross-validation and grid search for model optimization. Performance was evaluated using area under the receiver operating characteristic curve, accuracy, precision, specificity, and sensitivity. The Friedman test and Wilcoxon paired test compared algorithm performance.ResultsI-Level disease identification metrics mostly surpassed 0.90. II-Level classification metrics generally exceeded 0.80. For III-level diseases, models maintained high recognition rates for several common conditions. Logistic regression showed consistent performance comparable to other algorithms.ConclusionThe framework performed admirably in discerning both primary disease categories and their respective subtypes. The objective of NTAA prediagnosis based solely on superficial information could be realized. Logistic regression proves sufficient for this task, with no significant benefits from more complex algorithms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.